Century Therapeutics, Inc. — Form 8-K
Report date: October 2, 2026. This is an event report, not a quarterly or annual financial report.
Business context
The company announced that nonclinical data from its iPSC-derived cell therapy platform were presented at the European Association for the Study of Diabetes (EASD) on October 2, 2026, in Milan, Italy. The filing references a press release and presentation slides as exhibits but does not include their substantive contents in the provided text.
Financial information
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics, nor does it provide comparable-period results or financial guidance.
Disclosure and outlook
The press release (Exhibit 99.1) is furnished and is not deemed filed for purposes of Exchange Act Section 18, except as expressly incorporated by reference elsewhere. The presentation slides (Exhibit 99.2) are filed. The company states it has no obligation to update, supplement, or amend the slides.
Key facts to verify
- Review Exhibits 99.1 and 99.2 for the nonclinical findings, methods, and any caveats not included in the filing text provided.
- Check subsequent company disclosures for updates to the research and its development plans.